Evidence map›Paper›PMID 32277359›Full record

ArticleCEN case reports2020

Ask-Upmark kidney in a girl with neurofibromatosis type 1.

Yuri Dote, Tetsuya Kibe, Tomotaka Murakami, Midori Awazu

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in CEN case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yuri DoteDepartment of Pediatrics, Seirei-Mikatahara General Hospital, 3453 Mikatahara, Hamamatsu, Shizuoka, 433-8558, Japan. ngiyuri@gmail.com.
Tetsuya KibeDepartment of Pediatrics, Seirei-Mikatahara General Hospital, 3453 Mikatahara, Hamamatsu, Shizuoka, 433-8558, Japan.
Tomotaka MurakamiDepartment of Pediatrics, Seirei-Mikatahara General Hospital, 3453 Mikatahara, Hamamatsu, Shizuoka, 433-8558, Japan.
Midori AwazuDepartment of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Seirei Mikatabara General Hospital · JPKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ask-Upmark kidney (AUK) is a scarred segment of the kidney, characterized by formation of primitive tubular and glomerular structures, and sporadically diagnosed as a cause of hypertension (HTN). A 6-year-old girl with neurofibromatosis type 1 (NF1) and moyamoya syndrome had severe HTN. Based on past history, she had HTN at the age of 1.5 years. Laboratory examination revealed slightly elevated plasma and renal venous renin activity without lateralization. No evidence of pheochromocytoma, or coarctation of the aorta was found. Contrast-enhanced computed tomography (CT) showed an area of hypoperfusion in the upper and middle poles with reduced size of the right kidney. The results of dimercaptosuccinic acid scintigraphy were in accordance with those of contrast-enhanced CT. Selected renal arteriography revealed a paucity of peripheral vascularity in the same parts of the right kidney. In the absence of a history of urinary tract infection and vesicoureteral reflux by cystography, we presumed that the severe HTN may be due to segmental hypoplasia of the kidney, AUK, with a possible contribution from NF1. Although renal artery stenosis and pheochromocytoma are well-known causes of HTN in NF1, this case demonstrates that HTN can be caused by AUK in patients with NF1.

Indexed as

AngiographyAntihypertensive AgentsChildColobomaContrast MediaFemaleHumansHypertensionKidneyKidney GlomerulusMoyamoya DiseaseNeurofibromatosis 1ProteinuriaRadionuclide ImagingRenal InsufficiencyReninAntihypertensive AgentsContrast MediaReninSuccimerAsk-Upmark kidneyHypertensionNeurofibromatosis type 1Renal scarring

Identifiers

PMID32277359
PMCPMC7320095
OpenAlexW3015965078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.